2.4.0.8153 - Disclosure - Summary Information Regarding Options and Warrants (Detail)truefalsefalse1false USDfalsefalse$eol_PE10315---13S-1-0008_STD_90_20130331_0http://www.sec.gov/CIK0001069308duration2013-01-01T00:00:002013-03-31T00:00:00sharesStandardhttp://www.xbrl.org/2003/instanceshares0iso4217_USD_per_sharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instanceshares0USDUSD$2false USDfalsefalse$eol_PE10315---13S-1-0008_STD_366_20121231_0http://www.sec.gov/CIK0001069308duration2012-01-01T00:00:002012-12-31T00:00:00sharesStandardhttp://www.xbrl.org/2003/instanceshares0iso4217_USD_per_sharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instanceshares0USDUSD$3false USDfalsefalse$eol_PE10315---13S-1-0008_STD_365_20111231_0http://www.sec.gov/CIK0001069308duration2011-01-01T00:00:002011-12-31T00:00:00sharesStandardhttp://www.xbrl.org/2003/instanceshares0iso4217_USD_per_sharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instanceshares0USDUSD$4false USDfalsefalse$eol_PE10315---13S-1-0008_STD_365_20101231_0http://www.sec.gov/CIK0001069308duration2010-01-01T00:00:002010-12-31T00:00:00sharesStandardhttp://www.xbrl.org/2003/instanceshares0iso4217_USD_per_sharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instanceshares0USDUSD$5false USDfalsefalse$eol_PE10315---13S-1-0008_STD_365_20091231_0http://www.sec.gov/CIK0001069308duration2009-01-01T00:00:002009-12-31T00:00:00sharesStandardhttp://www.xbrl.org/2003/instanceshares0iso4217_USD_per_sharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instanceshares0USDUSD$6false USDfalsefalse$eol_PE10315---13S-1-0008_STD_366_20081231_0http://www.sec.gov/CIK0001069308duration2008-01-01T00:00:002008-12-31T00:00:00sharesStandardhttp://www.xbrl.org/2003/instanceshares0iso4217_USD_per_sharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instanceshares0USDUSD$7false USDfalsefalse$eol_PE10315---13S-1-0008_STD_365_20071231_0http://www.sec.gov/CIK0001069308duration2007-01-01T00:00:002007-12-31T00:00:00sharesStandardhttp://www.xbrl.org/2003/instanceshares0iso4217_USD_per_sharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instanceshares0USDUSD$1true 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForwardus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Options2false 5us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberus-gaap_truenainstantfalsefalsefalsefalsefalsetruefalsefalseperiodStartLabel1truefalsefalse824620824620falsefalsefalse2truefalsefalse442923442923falsefalsefalse3truefalsefalse385516385516falsefalsefalse4truefalsefalse480833480833falsefalsefalse5truefalsefalse388048388048falsefalsefalse6truefalsefalse259565259565falsefalsefalse7truefalsefalse190426190426falsefalsefalsexbrli:sharesItemTypesharesNumber of options outstanding, including both vested and non-vested options.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i)-(ii) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false1Number of Shares, Outstanding at beginning of period3false 5us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalsepositiveLabel1truefalsefalse125000125000falsefalsefalse2truefalsefalse411938411938falsefalsefalse3truefalsefalse7615776157falsefalsefalse4truefalsefalse3813838138falsefalsefalse5truefalsefalse193583193583falsefalsefalse6truefalsefalse160100160100falsefalsefalse7truefalsefalse7347573475falsefalsefalsexbrli:sharesItemTypesharesNet number of share options (or share units) granted during the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false1Options, Granted4false 5us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercisedus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1falsefalsefalse00  falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4truefalsefalse-36284-36284falsefalsefalse5truefalsefalse-15193-15193falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesNumber of share options (or share units) exercised during the current period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28,29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(2) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30 -Article 5 false1Options, Exercised5false 5us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsetruenegatedTerseLabel1truefalsefalse-46331-46331falsefalsefalse2truefalsefalse-30241-30241falsefalsefalse3truefalsefalse-18750-18750falsefalsefalse4truefalsefalse-97171-97171falsefalsefalse5truefalsefalse-85605-85605falsefalsefalse6truefalsefalse-31617-31617falsefalsefalse7truefalsefalse-4336-4336falsefalsefalsexbrli:sharesItemTypesharesFor presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(3)-(4) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false1Options, Forfeited and canceled6false 5us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberus-gaap_truenainstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse903289903289falsefalsefalse2truefalsefalse824620824620falsefalsefalse3truefalsefalse442923442923falsefalsefalse4truefalsefalse385516385516falsefalsefalse5truefalsefalse480833480833falsefalsefalse6truefalsefalse388048388048falsefalsefalse7truefalsefalse259565259565falsefalsefalsexbrli:sharesItemTypesharesNumber of options outstanding, including both vested and non-vested options.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i)-(ii) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false1Number of Shares, Outstanding at end of period7true 4opxa_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstractopxa_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Weighted Average Exercise Price, Options8false 5us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceus-gaap_truenainstantfalsefalsefalsefalsefalsetruefalsefalseperiodStartLabel1truefalsefalse5.545.54USD$falsetruefalse2truefalsefalse7.717.71USD$falsetruefalse3truefalsefalse8.608.60USD$falsetruefalse4truefalsefalse14.8014.80USD$falsetruefalse5truefalsefalse25.8825.88USD$falsetruefalse6truefalsefalse39.1639.16USD$falsetruefalse7truefalsefalse45.9245.92USD$falsetruefalsenum:perShareItemTypedecimalWeighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false3Weighted average exercise price options, Beginning balance9false 5opxa_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantInPeriodWeightedAverageExercisePriceopxa_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse2.342.34USD$falsetruefalse2truefalsefalse3.683.68USD$falsetruefalse3truefalsefalse6.296.29USD$falsetruefalse4truefalsefalse8.348.34USD$falsetruefalse5truefalsefalse3.833.83USD$falsetruefalse6truefalsefalse4.504.50USD$falsetruefalse7truefalsefalse21.1221.12USD$falsetruefalsenum:perShareItemTypedecimalShare Based Compensation Arrangements By Share Based Payment Award Options Grant In Period Weighted Average Exercise PriceNo definition available.false3Weighted average exercise price options, Granted10false 5opxa_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageExercisePriceopxa_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00  USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4truefalsefalse3.563.56USD$falsetruefalse5truefalsefalse4.214.21USD$falsetruefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsenum:perShareItemTypedecimalShare Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Exercise PriceNo definition available.false3Weighted average exercise price options, Exercised11false 5us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse4.734.73USD$falsetruefalse2truefalsefalse11.8011.80USD$falsetruefalse3truefalsefalse20.0020.00USD$falsetruefalse4truefalsefalse36.6236.62USD$falsetruefalse5truefalsefalse42.2242.22USD$falsetruefalse6truefalsefalse24.4124.41USD$falsetruefalse7truefalsefalse30.9630.96USD$falsetruefalsenum:perShareItemTypedecimalWeighted average price of options that were either forfeited or expired.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(3)-(4) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false3Weighted average exercise price options, Forfeited and canceled12false 5us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceus-gaap_truenainstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse5.145.14USD$falsetruefalse2truefalsefalse5.545.54USD$falsetruefalse3truefalsefalse7.717.71USD$falsetruefalse4truefalsefalse8.608.60USD$falsetruefalse5truefalsefalse14.8014.80USD$falsetruefalse6truefalsefalse25.8825.88USD$falsetruefalse7truefalsefalse39.1639.16USD$falsetruefalsenum:perShareItemTypedecimalWeighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false3Weighted average exercise price options, Ending balance13false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8false USDtruefalse$eol_PE10315---13S-1-0008_STD_366_20121231_0_716644x824137http://www.sec.gov/CIK0001069308duration2012-01-01T00:00:002012-12-31T00:00:00falsefalseWarrantsus-gaap_FinancialInstrumentAxisxbrldihttp://xbrl.org/2006/xbrldiopxa_WarrantShareMemberus-gaap_FinancialInstrumentAxisexplicitMembersharesStandardhttp://www.xbrl.org/2003/instanceshares0iso4217_USD_per_sharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instanceshares0USDUSD$nanafalse0Warrants14true 4opxa_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAbstractopxa_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Warrants15false 5opxa_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingNumberopxa_falsenainstantfalsefalsefalsefalsefalsetruefalsefalseperiodStartLabel1falsefalsefalse00falsefalsefalse2truefalsefalse26075502607550falsefalsefalse3truefalsefalse28648732864873falsefalsefalse4truefalsefalse31691693169169falsefalsefalse5truefalsefalse25997992599799falsefalsefalse6truefalsefalse917590917590falsefalsefalse7truefalsefalse917590917590falsefalsefalsexbrli:sharesItemTypesharesShare Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other than Options Outstanding, NumberNo definition available.false1Number of Shares, Outstanding at beginning of period16false 5us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse14361211436121falsefalsefalse3truefalsefalse414649414649falsefalsefalse4truefalsefalse19661966falsefalsefalse5truefalsefalse801143801143falsefalsefalse6truefalsefalse16822091682209falsefalsefalse7truefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesThe number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false1Warrants, Granted17false 5opxa_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodopxa_falsenadurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1falsefalsefalse00falsefalsefalse2truefalsefalse00falsefalsefalse3truefalsefalse00falsefalsefalse4truefalsefalse-17102-17102falsefalsefalse5truefalsefalse-179691-179691falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Exercises in PeriodNo definition available.false1Warrants, Exercised18false 5opxa_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCancelledAndForfeitedInPeriodopxa_falsenadurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1falsefalsefalse00falsefalsefalse2truefalsefalse-464584-464584falsefalsefalse3truefalsefalse-671972-671972falsefalsefalse4truefalsefalse-289160-289160falsefalsefalse5truefalsefalse-52082-52082falsefalsefalse6truefalsefalse00falsefalsefalse7truefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesShare Based Compensation Arrangement by Share Based Payment Award, Equity Instruments Other than Options, Cancelled and Forfeited in PeriodNo definition available.false1Warrants, Forfeited and canceled19false 5opxa_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingNumberopxa_falsenainstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1falsefalsefalse00falsefalsefalse2truefalsefalse35790873579087falsefalsefalse3truefalsefalse26075502607550falsefalsefalse4truefalsefalse28648732864873falsefalsefalse5truefalsefalse31691693169169falsefalsefalse6truefalsefalse25997992599799falsefalsefalse7truefalsefalse917590917590falsefalsefalsexbrli:sharesItemTypesharesShare Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other than Options Outstanding, NumberNo definition available.false1Number of Shares, Outstanding at end of period20true 4opxa_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePriceAbstractopxa_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Weighted Average Exercise Price, Warrants21false 5opxa_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsOutstandingWeightedAverageExercisePriceopxa_falsenainstantfalsefalsefalsefalsefalsetruefalsefalseperiodStartLabel1falsefalsefalse00falsefalsefalse2truefalsefalse6.666.66USD$falsetruefalse3truefalsefalse11.0011.00USD$falsetruefalse4truefalsefalse27.7227.72USD$falsetruefalse5truefalsefalse32.6032.60USD$falsetruefalse6truefalsefalse78.0478.04USD$falsetruefalse7truefalsefalse78.0478.04USD$falsetruefalsenum:perShareItemTypedecimalShare Based Compensation Arrangement By Share Based Payment Award Other Than Options Outstanding Weighted Average Exercise PriceNo definition available.false3Weighted average exercise price warrants, Beginning balance22false 5opxa_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePriceopxa_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse2.562.56USD$falsetruefalse3truefalsefalse10.4410.44USD$falsetruefalse4truefalsefalse8.008.00USD$falsetruefalse5truefalsefalse6.686.68USD$falsetruefalse6truefalsefalse7.847.84USD$falsetruefalse7falsefalsefalse00falsefalsefalsenum:perShareItemTypedecimalShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Exercise PriceNo definition available.false3Weighted average exercise price warrants, Granted23false 5opxa_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePriceopxa_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4truefalsefalse8.408.40USD$falsetruefalse5truefalsefalse6.646.64USD$falsetruefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsenum:perShareItemTypedecimalShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Exercises in Period, Weighted Average Exercise PriceNo definition available.false3Weighted average exercise price warrants, Exercised24false 5opxa_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCanceledAndForfeitedInPeriodWeightedAverageExercisePriceopxa_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse6.126.12USD$falsetruefalse3truefalsefalse23.7223.72USD$falsetruefalse4truefalsefalse117.60117.60USD$falsetruefalse5truefalsefalse20.0020.00USD$falsetruefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalsenum:perShareItemTypedecimalShare Based Compensation Arrangement by Share Based Payment Award, Equity Instruments Other than Options, Canceled and Forfeited in Period, Weighted Average Exercise PriceNo definition available.false3Weighted average exercise price warrants, Forfeited and canceled25false 5opxa_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsOutstandingWeightedAverageExercisePriceopxa_falsenainstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1falsefalsefalse00falsefalsefalse2truefalsefalse5.645.64USD$falsetruefalse3truefalsefalse6.666.66USD$falsetruefalse4truefalsefalse11.0011.00USD$falsetruefalse5truefalsefalse27.7227.72USD$falsetruefalse6truefalsefalse32.6032.60USD$falsetruefalse7truefalsefalse78.0478.04USD$falsetruefalsenum:perShareItemTypedecimalShare Based Compensation Arrangement By Share Based Payment Award Other Than Options Outstanding Weighted Average Exercise PriceNo definition available.false3Weighted average exercise price warrants, Ending balancefalseSummary Information Regarding Options and Warrants (Detail) (USD $)UnKnownNoRoundingNoRoundingUnKnowntruefalsefalseSheethttp://www.opexatherapeutics.com/taxonomy/role/DisclosureSummaryInformationRegardingOptionsAndWarrants725